Posted by Michael Wonder on 24 Sep 2025
Teva and Medincell’s risperidone LAI approved in Canada as Longavo
23 September 2025 - Teva Canada has received regulatory approval for risperidone long-acting injection from Health Canada for the treatment of schizophrenia in adults.
Risperidone long-acting injection formulated with Medincell’s proprietary technology is now approved in the US, South Korea and Canada.
